Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 6 | 2019 | 67 | 2.060 |
Why?
|
| Placenta | 4 | 2018 | 76 | 1.800 |
Why?
|
| Angiotensin I | 7 | 2016 | 239 | 1.490 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 111 | 1.470 |
Why?
|
| Peptide Fragments | 7 | 2016 | 430 | 1.380 |
Why?
|
| Uterus | 4 | 2016 | 106 | 1.360 |
Why?
|
| Kidney | 9 | 2015 | 528 | 1.280 |
Why?
|
| Oxidative Stress | 5 | 2019 | 265 | 1.270 |
Why?
|
| Renin | 9 | 2015 | 109 | 1.180 |
Why?
|
| Pregnancy | 13 | 2019 | 1069 | 1.010 |
Why?
|
| Peptidyl-Dipeptidase A | 6 | 2015 | 132 | 0.980 |
Why?
|
| Rats | 19 | 2019 | 1946 | 0.980 |
Why?
|
| Blood Pressure | 11 | 2016 | 901 | 0.930 |
Why?
|
| Hypertension | 6 | 2017 | 1024 | 0.880 |
Why?
|
| Animals | 24 | 2019 | 8579 | 0.720 |
Why?
|
| Uterine Artery | 3 | 2015 | 5 | 0.680 |
Why?
|
| Pseudopregnancy | 3 | 2016 | 4 | 0.640 |
Why?
|
| Oxygen | 2 | 2017 | 152 | 0.610 |
Why?
|
| Microcirculation | 2 | 2016 | 72 | 0.600 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2019 | 923 | 0.570 |
Why?
|
| Hemodynamics | 1 | 2019 | 168 | 0.560 |
Why?
|
| Sodium Chloride, Dietary | 4 | 2012 | 28 | 0.560 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2015 | 19 | 0.540 |
Why?
|
| Endocannabinoids | 2 | 2015 | 43 | 0.530 |
Why?
|
| Female | 24 | 2019 | 21532 | 0.530 |
Why?
|
| Down-Regulation | 2 | 2015 | 145 | 0.530 |
Why?
|
| Ovariectomy | 4 | 2008 | 204 | 0.510 |
Why?
|
| Embryo Implantation | 2 | 2015 | 59 | 0.510 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 2016 | 3 | 0.500 |
Why?
|
| Dinoprostone | 1 | 2016 | 37 | 0.500 |
Why?
|
| Femoral Artery | 1 | 2016 | 50 | 0.490 |
Why?
|
| Angiotensin II | 7 | 2015 | 244 | 0.490 |
Why?
|
| Erythropoietin | 3 | 2015 | 33 | 0.480 |
Why?
|
| Amidohydrolases | 2 | 2015 | 9 | 0.470 |
Why?
|
| Chorionic Villi | 1 | 2015 | 8 | 0.470 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 1129 | 0.460 |
Why?
|
| Umbilical Cord | 1 | 2015 | 8 | 0.450 |
Why?
|
| Ultrasonography | 1 | 2018 | 417 | 0.450 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2015 | 5 | 0.440 |
Why?
|
| Receptors, Cannabinoid | 1 | 2015 | 35 | 0.440 |
Why?
|
| Nitric Oxide Synthase Type I | 2 | 2012 | 18 | 0.430 |
Why?
|
| MicroRNAs | 1 | 2017 | 197 | 0.430 |
Why?
|
| RNA, Messenger | 6 | 2015 | 545 | 0.430 |
Why?
|
| Rats, Inbred Lew | 8 | 2012 | 123 | 0.420 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 379 | 0.400 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2013 | 22 | 0.390 |
Why?
|
| Receptors, Angiotensin | 1 | 2013 | 61 | 0.390 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2013 | 64 | 0.380 |
Why?
|
| Ornithine | 1 | 2012 | 4 | 0.370 |
Why?
|
| Estrogens | 3 | 2008 | 210 | 0.360 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 575 | 0.360 |
Why?
|
| Inflammation | 2 | 2012 | 557 | 0.350 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 60 | 0.350 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 85 | 0.350 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 71 | 0.340 |
Why?
|
| Kidney Failure, Chronic | 2 | 2012 | 548 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 842 | 0.330 |
Why?
|
| Fetal Growth Retardation | 3 | 2017 | 34 | 0.330 |
Why?
|
| Decidua | 3 | 2016 | 18 | 0.320 |
Why?
|
| Kidney Diseases | 3 | 2012 | 249 | 0.310 |
Why?
|
| Nitric Oxide Synthase | 1 | 2006 | 43 | 0.250 |
Why?
|
| Mice, Knockout | 3 | 2017 | 486 | 0.240 |
Why?
|
| Renin-Angiotensin System | 5 | 2012 | 178 | 0.230 |
Why?
|
| Regional Blood Flow | 2 | 2016 | 95 | 0.230 |
Why?
|
| Rats, Transgenic | 3 | 2019 | 48 | 0.210 |
Why?
|
| Mice | 5 | 2017 | 2720 | 0.200 |
Why?
|
| Pregnancy, Animal | 2 | 2014 | 20 | 0.190 |
Why?
|
| Angiotensinogen | 2 | 2019 | 59 | 0.180 |
Why?
|
| Blotting, Western | 2 | 2012 | 328 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2012 | 37 | 0.150 |
Why?
|
| Nitrates | 2 | 2012 | 29 | 0.150 |
Why?
|
| Proteinuria | 2 | 2011 | 55 | 0.150 |
Why?
|
| Nitric Oxide | 2 | 2012 | 124 | 0.150 |
Why?
|
| C-Reactive Protein | 2 | 2012 | 248 | 0.140 |
Why?
|
| Humans | 8 | 2017 | 34562 | 0.140 |
Why?
|
| Glycerides | 2 | 2015 | 14 | 0.140 |
Why?
|
| Arachidonic Acids | 2 | 2015 | 28 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 600 | 0.130 |
Why?
|
| Young Adult | 2 | 2015 | 2831 | 0.130 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2017 | 19 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 28 | 0.130 |
Why?
|
| Fetus | 1 | 2018 | 91 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 137 | 0.130 |
Why?
|
| Oximetry | 1 | 2016 | 33 | 0.120 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2015 | 4 | 0.120 |
Why?
|
| Protein Precursors | 1 | 2015 | 27 | 0.120 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 114 | 0.120 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 44 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2015 | 63 | 0.110 |
Why?
|
| Placental Circulation | 1 | 2015 | 2 | 0.110 |
Why?
|
| Rats, Nude | 2 | 2012 | 48 | 0.110 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 70 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 73 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 84 | 0.110 |
Why?
|
| Male | 6 | 2016 | 20740 | 0.110 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 87 | 0.110 |
Why?
|
| Infusion Pumps | 1 | 2015 | 9 | 0.110 |
Why?
|
| Superoxides | 1 | 2015 | 24 | 0.110 |
Why?
|
| Endopeptidases | 1 | 2015 | 34 | 0.110 |
Why?
|
| Collagen | 2 | 2015 | 240 | 0.110 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 13 | 0.110 |
Why?
|
| Vascular Resistance | 1 | 2014 | 33 | 0.110 |
Why?
|
| Cardiac Output | 1 | 2014 | 37 | 0.110 |
Why?
|
| Vasoconstriction | 1 | 2014 | 46 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2015 | 204 | 0.100 |
Why?
|
| Forearm | 1 | 2014 | 49 | 0.100 |
Why?
|
| Myometrium | 1 | 2013 | 11 | 0.100 |
Why?
|
| Aldosterone | 3 | 2008 | 27 | 0.090 |
Why?
|
| Gestational Age | 1 | 2013 | 134 | 0.090 |
Why?
|
| Biopterin | 1 | 2012 | 3 | 0.090 |
Why?
|
| Nitrites | 1 | 2012 | 22 | 0.090 |
Why?
|
| Anemia | 1 | 2012 | 58 | 0.090 |
Why?
|
| Mutation | 1 | 2015 | 532 | 0.090 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2012 | 21 | 0.090 |
Why?
|
| Neprilysin | 1 | 2012 | 31 | 0.090 |
Why?
|
| Fibrosis | 2 | 2015 | 131 | 0.090 |
Why?
|
| Blastocyst | 1 | 2011 | 11 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 97 | 0.090 |
Why?
|
| Fetal Weight | 1 | 2011 | 7 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2014 | 926 | 0.090 |
Why?
|
| Gene Expression | 1 | 2013 | 363 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 526 | 0.090 |
Why?
|
| Adult | 2 | 2015 | 10030 | 0.090 |
Why?
|
| Cell Separation | 1 | 2012 | 93 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2012 | 62 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 281 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2012 | 106 | 0.090 |
Why?
|
| Cell Transplantation | 1 | 2012 | 65 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 118 | 0.090 |
Why?
|
| Models, Animal | 2 | 2011 | 198 | 0.080 |
Why?
|
| Isoenzymes | 2 | 2011 | 72 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2012 | 183 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 91 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2012 | 182 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 115 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2012 | 633 | 0.080 |
Why?
|
| Heart Failure | 1 | 2016 | 780 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2008 | 26 | 0.070 |
Why?
|
| Diastole | 1 | 2008 | 100 | 0.070 |
Why?
|
| Animals, Congenic | 1 | 2007 | 14 | 0.070 |
Why?
|
| Hypertrophy | 1 | 2007 | 36 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 44 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 86 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 87 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 20 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2006 | 57 | 0.060 |
Why?
|
| Kidney Cortex | 1 | 2006 | 25 | 0.060 |
Why?
|
| Kidney Medulla | 1 | 2006 | 29 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 184 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 185 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2007 | 268 | 0.060 |
Why?
|
| Age Factors | 1 | 2008 | 1262 | 0.050 |
Why?
|
| Aging | 1 | 2007 | 1010 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2015 | 302 | 0.040 |
Why?
|
| Middle Aged | 1 | 2012 | 12726 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 35 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 48 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 67 | 0.030 |
Why?
|
| Monoglycerides | 1 | 2014 | 2 | 0.030 |
Why?
|
| Benzodioxoles | 1 | 2014 | 6 | 0.030 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2014 | 12 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2014 | 42 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 206 | 0.030 |
Why?
|
| Carbamates | 1 | 2014 | 18 | 0.030 |
Why?
|
| Benzamides | 1 | 2014 | 60 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 657 | 0.030 |
Why?
|
| Piperidines | 1 | 2014 | 141 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 400 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 43 | 0.020 |
Why?
|
| Absorption | 1 | 2012 | 16 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2012 | 26 | 0.020 |
Why?
|
| Bioartificial Organs | 1 | 2012 | 26 | 0.020 |
Why?
|
| Albumins | 1 | 2012 | 47 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2011 | 17 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 123 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 82 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2011 | 21 | 0.020 |
Why?
|
| Fetal Development | 1 | 2011 | 27 | 0.020 |
Why?
|
| Cyclopentanes | 1 | 2011 | 17 | 0.020 |
Why?
|
| Quinolines | 1 | 2011 | 29 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2011 | 23 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 216 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2011 | 40 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 265 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 182 | 0.020 |
Why?
|
| Vasodilation | 1 | 2011 | 96 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 177 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 257 | 0.020 |
Why?
|
| Estradiol | 1 | 2011 | 156 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 889 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 432 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2012 | 435 | 0.020 |
Why?
|
| Heart Failure, Diastolic | 1 | 2008 | 15 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 2006 | 31 | 0.020 |
Why?
|
| Heart Rate | 1 | 2006 | 372 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 4137 | 0.010 |
Why?
|